title: Usefulness of HeLa cells to evaluate inverse agonistic activity of antihistamines.
abstract: Antihistamines are thought to antagonize histamine and prevent it from binding to the histamine H1 receptor (H1R). However, recent studies indicate that antihistamines are classified into two groups, i.e., inverse agonists and neutral antagonists on the basis of their ability to down-regulate the constitutive activity of H1R. As H1R is an allergy-sensitive gene whose expression influences the severity of allergic symptoms, inverse agonists should more potently alleviate allergic symptoms than neutral antagonists by inhibiting H1R constitutive activity. Therefore, it is important to assess inverse agonistic activity of antihistamines. Here we report a novel assay method using HeLa cells expressing H1R endogenously for evaluation of inverse agonistic activity of antihistamines. Pretreatment with inverse agonists down-regulated H1R gene expression below to its basal level. On the other hand, basal H1R mRNA expression was unchanged by neutral antagonist pretreatment. Both inverse agonists and neutral antagonists suppressed histamine-induced H1R mRNA elevation. Classification of antihistamines on the basis of their suppressive activity of basal H1R gene expression was consistent with that of inositol phosphate accumulation in H1R-overexpressed cells. Our data suggest that the assay method using HeLa cells is more convenient and useful than the existing methods and may contribute to develop new antihistamines with inverse agonistic activity.
authors: Department of Molecular Pharmacology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8505, Japan.
authors: Hiroyuki
authors: H
authors: Mizuguchi
authors: Shohei
authors: S
authors: Ono
authors: Masashi
authors: M
authors: Hattori
authors: Yohei
authors: Y
authors: Sasaki
authors: Hiroyuki
authors: H
authors: Fukui
mesh_terms: D054316:Biomarkers, Pharmacological / Q000032:analysis; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D054314:Drug Inverse Agonism; D005240:Feasibility Studies; D005786:Gene Expression Regulation / Q000187:drug effects; D006367:HeLa Cells; D017442:Histamine Agonists / Q000494:pharmacology*; D006633:Histamine Antagonists / Q000494:pharmacology*; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D011969:Receptors, Histamine H1 / Q000235:genetics / Q000378:metabolism*
chemical_list: D054316:Biomarkers, Pharmacological; D017442:Histamine Agonists; D006633:Histamine Antagonists; D007295:Inositol Phosphates; D012333:RNA, Messenger; D011969:Receptors, Histamine H1